JP2019048806A5 - - Google Patents

Download PDF

Info

Publication number
JP2019048806A5
JP2019048806A5 JP2018185491A JP2018185491A JP2019048806A5 JP 2019048806 A5 JP2019048806 A5 JP 2019048806A5 JP 2018185491 A JP2018185491 A JP 2018185491A JP 2018185491 A JP2018185491 A JP 2018185491A JP 2019048806 A5 JP2019048806 A5 JP 2019048806A5
Authority
JP
Japan
Prior art keywords
salt
compound
organic acid
formula
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018185491A
Other languages
English (en)
Japanese (ja)
Other versions
JP7098496B2 (ja
JP2019048806A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019048806A publication Critical patent/JP2019048806A/ja
Publication of JP2019048806A5 publication Critical patent/JP2019048806A5/ja
Application granted granted Critical
Publication of JP7098496B2 publication Critical patent/JP7098496B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018185491A 2016-12-21 2018-09-28 7H-ピロロ[2,3-d]ピリミジン誘導体の製造方法及びその合成中間体 Active JP7098496B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016247607 2016-12-21
JP2016247607 2016-12-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018518551A Division JP6434678B2 (ja) 2016-12-21 2017-12-20 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法及びその合成中間体

Publications (3)

Publication Number Publication Date
JP2019048806A JP2019048806A (ja) 2019-03-28
JP2019048806A5 true JP2019048806A5 (enExample) 2021-02-04
JP7098496B2 JP7098496B2 (ja) 2022-07-11

Family

ID=62627423

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018518551A Active JP6434678B2 (ja) 2016-12-21 2017-12-20 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法及びその合成中間体
JP2018185491A Active JP7098496B2 (ja) 2016-12-21 2018-09-28 7H-ピロロ[2,3-d]ピリミジン誘導体の製造方法及びその合成中間体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018518551A Active JP6434678B2 (ja) 2016-12-21 2017-12-20 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法及びその合成中間体

Country Status (12)

Country Link
US (3) US11673900B2 (enExample)
EP (1) EP3560932A4 (enExample)
JP (2) JP6434678B2 (enExample)
KR (1) KR102546513B1 (enExample)
CN (2) CN117865992A (enExample)
AU (2) AU2017384317C1 (enExample)
BR (1) BR112019012688A2 (enExample)
CA (1) CA3047891A1 (enExample)
IL (2) IL288080B2 (enExample)
MX (2) MX2019007542A (enExample)
TW (2) TWI854815B (enExample)
WO (1) WO2018117152A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180025940A (ko) 2015-07-07 2018-03-09 니뽄 다바코 산교 가부시키가이샤 7H-피롤로[2,3-d]피리미딘 유도체의 제조 방법 및 그의 중간체
IL288080B2 (en) 2016-12-21 2024-03-01 Leo Pharma As A process for the preparation of H7-pyrrolo[3,2-d]pyrimidine derivatives and their artificial intermediates
CN111560021B (zh) * 2020-06-30 2023-05-26 上海鲲博玖瑞医药科技发展有限公司 一种德高替尼中间体及其制备方法
CN111574540B (zh) * 2020-06-30 2023-08-29 云南华派医药科技有限公司 一种德高替尼的制备方法
CN111606929B (zh) * 2020-06-30 2023-07-07 中瀚(齐河县)生物医药科技有限公司 德高替尼的制备方法
AU2024238918A1 (en) 2023-03-17 2025-10-09 Leo Pharma A/S A method for the treatment of chronic hand eczema in patients with moderate to severe chronic hand eczema
TW202508595A (zh) 2023-05-04 2025-03-01 美商銳新醫藥公司 用於ras相關疾病或病症之組合療法
WO2025034702A1 (en) 2023-08-07 2025-02-13 Revolution Medicines, Inc. Rmc-6291 for use in the treatment of ras protein-related disease or disorder
WO2025080946A2 (en) 2023-10-12 2025-04-17 Revolution Medicines, Inc. Ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
WO2025240847A1 (en) 2024-05-17 2025-11-20 Revolution Medicines, Inc. Ras inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662960B2 (en) 2001-04-26 2010-02-16 Choongwae Pharma Corporation Beta-strand mimetics and method relating thereto
BRPI0318325B8 (pt) 2003-05-30 2021-05-25 Choongwae Pharma Corp compostos miméticos de beta-fita
US7230119B2 (en) 2004-08-25 2007-06-12 Biocryst Pharmaceuticals, Inc. Process for the preparation of substituted pyrrolidine derivatives and intermediates
ATE532786T1 (de) 2006-09-22 2011-11-15 Janssen Pharmaceutica Nv Spirobenzazepine als vasopressinantagonisten
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
GB2489382A (en) 2011-01-19 2012-09-26 Galapagos Nv Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
CN103570601B (zh) 2012-07-20 2016-03-30 重庆博腾制药科技股份有限公司 一种光学活性药物中间体的制备方法
HRP20171097T1 (hr) 2013-03-05 2017-10-06 Theravance Biopharma R&D Ip, Llc Inhibitori neprilizina
JP6500634B2 (ja) * 2015-06-24 2019-04-17 株式会社Ihi 溶接装置及び溶接方法
KR20180025940A (ko) 2015-07-07 2018-03-09 니뽄 다바코 산교 가부시키가이샤 7H-피롤로[2,3-d]피리미딘 유도체의 제조 방법 및 그의 중간체
JP2020502224A (ja) 2016-12-21 2020-01-23 日本たばこ産業株式会社 ヤヌスキナーゼ阻害剤の結晶形
IL288080B2 (en) * 2016-12-21 2024-03-01 Leo Pharma As A process for the preparation of H7-pyrrolo[3,2-d]pyrimidine derivatives and their artificial intermediates

Similar Documents

Publication Publication Date Title
JP2019048806A5 (enExample)
JP2019147825A5 (enExample)
JP2022043078A5 (enExample)
JP2019207442A5 (enExample)
JP2019194236A5 (enExample)
JP2018024670A5 (enExample)
JP2017222697A5 (enExample)
JP2016520672A5 (enExample)
JP2018193405A5 (enExample)
JP2016153424A5 (enExample)
JP2016148024A5 (enExample)
JP2010174033A5 (enExample)
JP2009535462A5 (enExample)
JP2011518833A5 (enExample)
JP2018529687A5 (enExample)
JP2018521020A5 (enExample)
JP2010501516A5 (enExample)
JP2016188255A5 (enExample)
JPWO2021220648A5 (enExample)
JP2009184932A5 (enExample)
JP2007526383A5 (enExample)
JP2010534246A5 (enExample)
JP2018145180A5 (enExample)
JP2021046426A5 (enExample)
JP2018009003A5 (enExample)